Orserdu

Generic Name/API: Elacestrant
Manufacturer: Stemline Therapeutics, Inc.
Packaging: Tablet Form
Storage: Between 20°C to 25°C
Dosage: 345 mg and 86mg
Strength: 345 mg and 86mg
Indication: An estrogen receptor antagonist is indicated to treat postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. This is with disease progression following at least one line of endocrine therapy.
No Indian generic option is available.
 
?>

About Elacestrant

Elacestrant is a prescribed medicine for the treatment of:

  • Postmenopausal women or adult men
  • Patients with are ER-positive, HER2-negative, ESR1-mutated advanced or metastatic
  • breast cancer.

Strength

Tablets of 345 mg and 86 mg (3)


Recommended Dosage

  • Patients with ESR1 mutations presence should be treated with Elacestrant.
  • The recommended Dosage for Elacestrant is 345mg taken daily with food.
  • Discontinue, disrupt or reduce dosage in the case of adverse effects.

Warning and precautions 

  • Dyslipidemia: hypercholesterolemia and hypertriglyceridemia can be caused by
  • Elacestrant. Check your lipid profile before starting treatment, and check it regularly.
  • Embryo-Fetal Toxicity: Elacestrant can harm the fetus. Advise of the potential risk to a fetus and to use effective contraception.

Common Elacestrant side-effects

  • Musculoskeletal pain
  • Nausea
  • Increased cholesterol
  • Increased AST
  • Increased triglycerides
  • Fatigue
  • Decreased hemoglobin
  • Vomiting
  • Increased ALT
  • Decreased sodium
  • Increased creatinine
  • Decreased appetite
  • Diarrhea
  • Headache
  • Constipation
  • Abdominal pain
  • Hot flush
  • Dyspepsia

Storage and handling

Store at room temperature between 20°C to 25°C

We follow a four-step process to procure the medicines:

  • Inquiry about the medicines: You submit a request for information about the medications you require using our portal, and we process your data. Within 24 hours, a Named Access Program Support member will contact you and provide you with all the assistance you need.
  • Verification Process: We assist patients in finding medications that are not yet approved and readily available in their home countries, Sansfro must confirm the availability and approval of the medicines they need. We also check the patient prescription and medical information.
  • Sourcing the Medicine: After completing the verification process, our staff will contact our vast network of suppliers to find your medicine. Following the process, our team gets the best rates of the medicines for you and ensures processing.
  • Safe Delivery: We will set up the consignment’s safe delivery after the final quote is approved. Additionally, our logistics experts can help you track your consignment. The named Access Program industry has a large number of unauthorized channels. To provide the medications safely and legally, we do so by adhering to the Standard Operating Procedures.

When importing medication, we will need the following documents from the patient:

  1. A valid prescription copy.
  2. An identity proof document.
  3. Details of the attending healthcare professional.
  4. A current address.

Once we have all these documents, the Sansfro team will initiate the application process for an import license. This license is essential to ensure that we can obtain the necessary medication once it receives government approval.

No news found.

About Sansfro

Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.

Know More...

FAQ'S

How does Elacestrant work?

Elacestrant works by blocking the estrogen receptor (ER) in hormones that receptor-positive breast cancer cells. It aims to lower the count of the ER, leading to the inhibition of tumor growth and cancer.

What types of breast cancer is Elacestrant intended to treat?

Elacestrant is used for the treatment of hormone receptor-positive, ER-positive, HER2- negative, ESR1-mutated advanced or metastatic breast cancer.

What are the side effects associated with Elacestrant?

Common side effects that Elacestrant can cause can vary, and it’s best to consult to the doctor; however, some side effects are decreased hemoglobin, vomiting, increased ALT, reduced sodium, and increased creatinine.

Where can I find more information about Elacestrant?

For the latest information about Elacestrant, you can consult official medical sources and clinical trial databases or reach out to our Patient Support Team at ‎(+91) 9315705373 or help@sansfro.com

Dr Anchal Aryan

Medical counselor

Patient Support Head Detail

Dr Anchal Aryan

Medical counselor

COTACT US NOW

Patient Stories

Great Customer support
Invimeds Health boasts an exceptional team that consistently provides excellent customer service. We extend our gratitude to Sachin.
Aamir Hussain
Leqembi for Grand father
Invimeds helped me for providing my grand father LEQEMBI for Alzheimers in far flung area of Uttarkhand.
Shivam Pandit
Thankyou Invimeds
Thank you Invimeds team for providing Zejula for my grand mother at earliest. This has helped us a lot to go ahead with her cancer treatment.
Satrudhan Shukla

Word Wide Delivery:

India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.

×